Gilotrif (afatinib tablets – Boehringer Ingelheim) — Cigna
Non-Small Cell Lung Cancer – Squamous Cell Carcinoma
Initial criteria
- Patient is age ≥ 18 years
- Patient has metastatic squamous cell carcinoma
- Patient has disease progression after treatment with platinum-based chemotherapy
Approval duration
1 year